Genetic manipulation of islet cells in autoimmune diabetes: From bench to bedside

Frontiers in Bioscience

Volumn 13, Issue 16, 2008, Pages 6155-6169

  Chuang, Yi Ping ^a   Chu, Chi Hong ^a   Sytwu, Huey Kang ^a,b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

IDDM; Immunopathogenesis; Insulin Promoter; Islet Transplantation; NOD; Review; T1D

Indexed keywords

MUS MUSCULUS;

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; HEME OXYGENASE 1; LEUKOCYTE ANTIGEN; SOCS1 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING; THIOREDOXIN; TUMOR NECROSIS FACTOR ALPHA;

CELL DEATH; CYTOTOXIC T LYMPHOCYTE; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANTIGENS, CD; CELL DEATH; DIABETES MELLITUS, TYPE 1; HEME OXYGENASE-1; HUMANS; INFLAMMATION; INTERFERON TYPE II; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; THIOREDOXINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 52049101547     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Article

References (156)

1. Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. Diabetes, 46, 271-86 (1997)
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med, 329, 977-86 (1993)
3. Wild, S., G. Roglic, A. Green, R. Sicree & H. King: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 27, 1047-53 (2004) (Pubitemid 38579764)
4. Onkamo, P., S. Vaananen, M. Karvonen & J. Tuomilehto: Worldwide increase in incidence of Type I diabetes - the analysis of the data on published incidence trends. Diabetologia, 42, 1395-403 (1999) (Pubitemid 30012309)
5. Castano, L. & G. S. Eisenbarth: Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol, 8, 647-79 (1990) (Pubitemid 20135642)
6. Barnett, A. H., C. Eff, R. D. Leslie & D. A. Pyke: Diabetes in identical twins. A study of 200 pairs.Diabetologia, 20, 87-93 (1981) (Pubitemid 11138466)
7. Smyth, D. J., J. D. Cooper, R. Bailey, S. Field, O. Burren, L. J. Smink, C. Guja, C. Ionescu-Tirgoviste, B. Widmer, D. B. Dunger, D. A. Savage, N. M. Walker, D. G. Clayton & J. A. Todd: A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet, 38, 617-9 (2006) (Pubitemid 43927300)
8. Vyse, T. J. & J. A. Todd: Genetic analysis of autoimmune disease. Cell, 85, 311-8 (1996) (Pubitemid 26160703)
9. Todd, J. A., N. M. Walker, J. D. Cooper, D. J. Smyth, K. Downes, V. Plagnol, R. Bailey, S. Nejentsev, S. F. Field, F.Payne, C. E. Lowe, J. S. Szeszko, J. P. Hafler, L. Zeitels, J. H. Yang, A. Vella, S. Nutland, H. E. Stevens, H. Schuilenburg, G. Coleman, M. Maisuria, W. Meadows, L. J. Smink, B. Healy, O. S. Burren, A. A. Lam, N. R. Ovington, J. Allen, E. Adlem, H. T. Leung, C. Wallace, J. M. Howson, C. Guja, C. Ionescu-Tirgoviste, M. J. Simmonds, J. M. Heward, S. C. Gough, D. B. Dunger, L. S. Wicker & D. G. Clayton: Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet, 39, 857-64 (2007) (Pubitemid 47018195)
10. Todd, J. A., J. I. Bell & H. O. McDevitt: HLA-DQ beta gene contributes to susceptibility and resistance to insulindependent diabetes mellitus. Nature, 329, 599-604 (1987) (Pubitemid 17140111)
11. Kawabata, Y., H. Ikegami, Y. Kawaguchi, T. Fujisawa, M. Shintani, M. Ono, M. Nishino, Y. Uchigata, I. Lee & T. Ogihara: Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes, 51, 545-51 (2002) (Pubitemid 34764816)
12. Rammensee, H. G., T. Friede & S. Stevanoviic: MHC ligands and peptide motifs: first listing. Immunogenetics, 41, 178-228 (1995)
13. Atkinson, M. A. & N. K. Maclaren: Islet cell autoantigens in insulin-dependent diabetes. J Clin Invest,92, 1608-16 (1993) (Pubitemid 23304521)
14. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri & Y. Tochino: Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu, 29, 1-13 (1980) (Pubitemid 10185796)
15. Kikutani, H. & S. Makino: The murine autoimmune diabetes model: NOD and related strains. Adv Immunol, 51, 285-322 (1992)
16. Delovitch, T. L. & B. Singh: The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity, 7, 727-38 (1997) (Pubitemid 28064887)
17. Bach, J. F. & D. Mathis: The NOD mouse. Res Immunol, 148, 285-6 (1997) (Pubitemid 27435910)
18. Christianson, S. W., L. D. Shultz & E. H. Leiter: Adoptive transfer of diabetes into immunodeficientNOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes, 42, 44-55 (1993) (Pubitemid 23013794)
19. Allison, J., L. C. Harrison, I. L. Campbell & J. F. Miller: Major histocompatibility complex molecules and the beta cell: inferences from transgenic models. Curr Top Microbiol Immunol, 156, 121-35 (1990) (Pubitemid 20128715)
20. Sarvetnick, N., D. Liggitt, S. L. Pitts, S. E. Hansen & T. A. Stewart: Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell, 52, 773-82 (1988) (Pubitemid 18078648)
21. Severinsson, L. & P. A. Peterson: Beta 2- microglobulin induces intracellular transport of human class I transplantation antigen heavy chains in Xenopus laevis oocytes. J Cell Biol, 99, 226-32 (1984) (Pubitemid 14096886)
22. Gagnerault, M. C., J. J. Luan, C. Lotton & F. Lepault: Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J Exp Med, 196, 369-77 (2002) (Pubitemid 34875666)
23. Zhang, Y., B. O'Brien, J. Trudeau, R. Tan, P. Santamaria & J. P. Dutz: In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes. J Immunol, 168, 1466-72 (2002) (Pubitemid 34094520)
24. Hoglund, P., J. Mintern, C. Waltzinger, W. Heath, C. Benoist & D. Mathis: Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med, 189, 331-9 (1999) (Pubitemid 29063254)
25. Trudeau, J. D., J. P. Dutz, E. Arany, D. J. Hill, W. E. Fieldus & D. T. Finegood: Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes? Diabetes, 49, 1-7 (2000) (Pubitemid 30022916)
26. Yamanouchi, J., J. Verdaguer, B. Han, A. Amrani, P. Serra & P. Santamaria: Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens. J Immunol, 171, 6900-9 (2003) (Pubitemid 37532126)
27. Gordon, J. W. & F. H. Ruddle: Gene transfer into mouse embryos: production of transgenic mice by pronuclear injection. Methods Enzymol, 101, 411-33 (1983) (Pubitemid 13071063)
28. Wilkie, T. M., R. L. Brinster & R. D. Palmiter: Germline and somatic mosaicism in transgenic mice. Dev Biol, 118, 9-18 (1986) (Pubitemid 17179009)
29. Palmiter, R. D. & R. L. Brinster: Germ-line transformation of mice. Annu Rev Genet, 20, 465-99 (1986)
30. Palmiter, R. D., H. Y. Chen & R. L. Brinster: Differential regulation of metallothionein-thymidine kinase fusion genes in transgenic mice and their offspring. Cell, 29, 701-10 (1982) (Pubitemid 12024856)
31. Melloul, D., S. Marshak & E. Cerasi: Regulation of insulin gene transcription. Diabetologia, 45, 309-26 (2002) (Pubitemid 34267353)
32. Hay, C. W. & K. Docherty: Comparative analysis of insulin gene promoters: implications for diabetes research. Diabetes, 55, 3201-13 (2006) (Pubitemid 44923575)
33. Suk, K., S. Kim, Y. H. Kim, K. A. Kim, I. Chang, H. Yagita, M. Shong & M. S. Lee: IFN-gamma/TNF-alphasynergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death. J Immunol, 166, 4481-9 (2001) (Pubitemid 32233732)
34. Pakala, S. V., M. Chivetta, C. B. Kelly & J. D. Katz: In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. J Exp Med, 189, 1053-62 (1999) (Pubitemid 29169822)
35. Kagi, D., A. Ho, B. Odermatt, A. Zakarian, P. S. Ohashi & T. W. Mak: TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes. J Immunol, 162, 4598-605 (1999) (Pubitemid 29314859)
36. Cantor, J. & K. Haskins: Effector function of diabetogenic CD4 Th1 T cell clones: a central role for TNF-alpha. J Immunol, 175, 7738-45 (2005) (Pubitemid 41713474)
37. Mathis, D., L. Vence & C. Benoist: beta-Cell death during progression to diabetes. Nature, 414, 792-8 (2001)
38. Eizirik, D. L. & T. Mandrup-Poulsen: A choice of death - the signal-transduction of immune-mediated betacell apoptosis. Diabetologia, 44, 2115-33 (2001) (Pubitemid 34015464)
39. Chong, M. M., H. E. Thomas & T. W. Kay: gamma- Interferon signaling in pancreatic beta-cells is persistent butcan be terminated by overexpression of suppressor of cytokine signaling-1. Diabetes, 50, 2744-51 (2001) (Pubitemid 33733125)
40. Thomas, H. E., J. L. Parker, R. D. Schreiber & T. W. Kay: IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. J Clin Invest, 102, 1249-57 (1998) (Pubitemid 28436285)
41. Kim, K. A., S. Kim, I. Chang, G. S. Kim, Y. K. Min, M. K. Lee, K. W. Kim & M. S. Lee: IFN gamma/TNF alpha synergism in MHC class II induction: effect of nicotinamide on MHC class II expression but not on isletcell apoptosis. Diabetologia, 45, 385-93 (2002) (Pubitemid 34267361)
42. Campbell, I. L., L. Oxbrow, M. Koulmanda & L. C. Harrison: IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse. J Immunol, 140, 1111-6 (1988) (Pubitemid 18088575)
43. Thomas, H. E., R. Darwiche, J. A. Corbett & T. W. Kay: Evidence that beta cell death in the nonobese diabetic mouse is Fas independent. J Immunol, 163, 1562-9 (1999) (Pubitemid 29352780)
44. Yamada, K., N. Takane-Gyotoku, X. Yuan, F. Ichikawa, C. Inada & K. Nonaka: Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia, 39, 1306-12 (1996) (Pubitemid 26356058)
45. Rabinovitch, A., W. L. Suarez-Pinzon, O. Sorensen & R. C. Bleackley: Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS- expressing cells and relationships to cytokines expressed in the islets. Endocrinology, 137, 2093-9 (1996) (Pubitemid 26133980)
46. Mandrup-Poulsen, T.: The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia, 39, 1005-29 (1996) (Pubitemid 26275930)
47. Eizirik, D. L., M. Flodstrom, A. E. Karlsen & N. Welsh: The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia, 39, 875-90 (1996) (Pubitemid 26249106)
48. Corbett, J. A., J. L. Wang, M. A. Sweetland, J. R. Lancaster, Jr. & M. L. McDaniel: Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. J Clin Invest, 90, 2384-91 (1992) (Pubitemid 23010057)
49. O'Brien, B. A., B. V. Harmon, D. P. Cameron & D. J. Allan: Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes, 46, 750-7 (1997) (Pubitemid 27188250)
50. Kurrer, M. O., S. V. Pakala, H. L. Hanson & J. D. Katz: Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci U S A, 94, 213-8 (1997) (Pubitemid 27027189)
51. Itoh, N., A. Imagawa, T. Hanafusa, M. Waguri, K. Yamamoto, H. Iwahashi, M. Moriwaki, H. Nakajima, J. Miyagawa, M. Namba, S. Makino, S. Nagata, N. Kono & Y. Matsuzawa: Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J Exp Med, 186, 613-8 (1997) (Pubitemid 27360805)
52. Chervonsky, A. V., Y. Wang, F. S. Wong, I. Visintin, R. A. Flavell, C. A. Janeway, Jr. & L. A. Matis: The role of Fas in autoimmune diabetes. Cell, 89, 17-24 (1997) (Pubitemid 27180581)
53. Kaneto, H., J. Fujii, H. G. Seo, K. Suzuki, T. Matsuoka, M. Nakamura, H. Tatsumi, Y. Yamasaki, T. Kamada & N. Taniguchi: Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes, 44, 733-8 (1995)
54. Held, W., H. R. MacDonald, I. L. Weissman, M. W. Hess & C. Mueller: Genes encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes. Proc Natl Acad Sci U S A, 87, 2239-43 (1990)
55. Higuchi, Y., P. Herrera, P. Muniesa, J. Huarte, D. Belin, P. Ohashi, P. Aichele, L. Orci, J. D. Vassalli & P. Vassalli: Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes. J Exp Med, 176, 1719-31 (1992)
56. Picarella, D. E., A. Kratz, C. B. Li, N. H. Ruddle & R. A. Flavell: Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. J Immunol, 150, 4136-50 (1993) (Pubitemid 23129795)
57. Jacob, C. O., S. Aiso, S. A. Michie, H. O. McDevitt & H. Acha-Orbea: Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci U S A, 87, 968-72 (1990)
58. Green, E. A., E. E. Eynon & R. A. Flavell: Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity, 9, 733-43 (1998) (Pubitemid 28557601)
59. Green, E. A., F. S. Wong, K. Eshima, C. Mora & R. A. Flavell: Neonatal tumor necrosis factor alpha promotes diabetes in nonobese diabetic mice by CD154-independent antigen presentation to CD8 (+) T cells. J Exp Med, 191, 225-38 (2000)
60. Lee, L. F., B. Xu, S. A. Michie, G. F. Beilhack, T. Warganich, S. Turley & H. O. McDevitt: The role of TNFalpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation. Proc Natl Acad Sci U S A, 102, 15995-6000 (2005) (Pubitemid 41552856)
61. Yang, X. D., R. Tisch, S. M. Singer, Z. A. Cao, R. S. Liblau, R. D. Schreiber & H. O. McDevitt: Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J Exp Med, 180, 995-1004 (1994) (Pubitemid 24256612)
62. Grewal, I. S., K. D. Grewal, F. S. Wong, D. E. Picarella, C. A. Janeway, Jr. & R. A. Flavell: Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive isletspecific T cells. J Exp Med, 184, 1963-74 (1996) (Pubitemid 26404486)
63. Boehm, U., T. Klamp, M. Groot & J. C. Howard: Cellular responses to interferon-gamma. Annu Rev Immunol, 15, 749-95 (1997)
64. Suarez-Pinzon, W., R. V. Rajotte, T. R. Mosmann & A. Rabinovitch: Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferongamma during beta-cell destruction. Diabetes, 45, 1350-7 (1996) (Pubitemid 26332897)
65. Sarvetnick, N., J. Shizuru, D. Liggitt, L. Martin, B. McIntyre, A. Gregory, T. Parslow & T. Stewart: Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature, 346, 844-7 (1990)
66. Debray-Sachs, M., C. Carnaud, C. Boitard, H. Cohen, I. Gresser, P. Bedossa & J. F. Bach: Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J Autoimmun, 4, 237-48 (1991)
67. van den Elsen, P. J., S. J. Gobin, M. C. van Eggermond & A. Peijnenburg: Regulation of MHC class I and II gene transcription: differences and similarities. Immunogenetics, 48, 208-21 (1998) (Pubitemid 28352187)
68. Luthman, M. & A. Holmgren: Rat liver thioredoxin and thioredoxin reductase: purification and characterization. Biochemistry, 21, 6628-33 (1982)
69. Nakamura, H., K. Nakamura & J. Yodoi: Redox regulation of cellular activation. Annu Rev Immunol, 15, 351-69 (1997) (Pubitemid 27169285)
70. Holmgren, A.: Thioredoxin. Annu Rev Biochem, 54, 237-71 (1985) (Pubitemid 15073647)
71. Hotta, M., F. Tashiro, H. Ikegami, H. Niwa, T. Ogihara, J. Yodoi & J. Miyazaki: Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J Exp Med, 188, 1445-51 (1998) (Pubitemid 28489581)
72. Ryter, S. W. & R. M. Tyrrell: The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties. Free Radic Biol Med, 28, 289-309 (2000) (Pubitemid 30084022)
73. Ryter, S. W., J. Alam & A. M. Choi: Heme oxygenase- 1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev, 86, 583-650 (2006)
74. Li, M., S. Peterson, D. Husney, M. Inaba, K. Guo, A. Kappas, S. Ikehara & N. G. Abraham: Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice. Cell Cycle, 6, 567-71 (2007) (Pubitemid 46440429)
75. Hu, C. M., H. H. Lin, M. T. Chiang, P. F. Chang & L. Y. Chau: Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in NOD mice. Diabetes, 56, 1240-7 (2007)
76. Chong, M. M., H. E. Thomas & T. W. Kay: Suppressor of cytokine signaling-1 regulates the sensitivity of pancreatic beta cells to tumor necrosis factor. J Biol Chem, 277, 27945-52 (2002) (Pubitemid 34966742)
77. Frigerio, S., T. Junt, B. Lu, C. Gerard, U. Zumsteg, G. A. Hollander & L. Piali: Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med, 8, 1414-20 (2002) (Pubitemid 36024137)
78. Cardozo, A. K., H. Heimberg, Y. Heremans, R. Leeman, B. Kutlu, M. Kruhoffer, T. Orntoft & D. L. Eizirik: A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary ratpancreatic beta-cells. J Biol Chem, 276, 48879-86 (2001)
79. Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, T. Miyazaki, N. Leonor, T. Taniguchi, T. Fujita, Y. Kanakura, S. Komiya & A. Yoshimura: A new protein containing an SH2 domain that inhibits JAK kinases. Nature, 387, 921-4 (1997) (Pubitemid 27289595)
80. Chong, M. M., Y. Chen, R. Darwiche, N. L. Dudek, W. Irawaty, P. Santamaria, J. Allison, T. W. Kay & H. E. Thomas: Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction. J Immunol, 172, 5714-21 (2004) (Pubitemid 38542076)
81. Rabinovitch, A.: Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation? Diabetes, 43, 613-21 (1994) (Pubitemid 24138771)
82. Katz, J. D., C. Benoist & D. Mathis: T helper cell subsets in insulin-dependent diabetes. Science, 268, 1185-8 (1995)
83. Shimizu, J., O. Kanagawa & E. R. Unanue: Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice. J Immunol, 151, 1723-30 (1993) (Pubitemid 23219311)
84. Haskins, K. & M. McDuffie: Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science, 249, 1433-6 (1990)
85. Rapoport, M. J., A. Jaramillo, D. Zipris, A. H. Lazarus, D. V. Serreze, E. H. Leiter, P. Cyopick, J. S. Danska & T. L. Delovitch: Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med, 178, 87-99 (1993) (Pubitemid 23173245)
86. Pennline, K. J., E. Roque-Gaffney & M. Monahan: Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol, 71, 169-75 (1994) (Pubitemid 24147233)
87. Mueller, R., T. Krahl & N. Sarvetnick: Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med, 184, 1093-9 (1996) (Pubitemid 26313566)
88. Mueller, R., L. M. Bradley, T. Krahl & N. Sarvetnick: Mechanism underlying counterregulation of autoimmune diabetes by IL-4. Immunity, 7, 411-8 (1997) (Pubitemid 27446015)
89. Falcone, M., B. Yeung, L. Tucker, E. Rodriguez, T. Krahl & N. Sarvetnick: IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic Islets. Clin Immunol, 98, 190-9 (2001)
90. Cardell, S. L.: The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in nonobese diabetic mice. Clin Exp Immunol, 143, 194-202 (2006)
91. You, S., N. Thieblemont, M. A. Alyanakian, J. F. Bach & L. Chatenoud: Transforming growth factor-beta and Tcell- mediated immunoregulation in the control of autoimmune diabetes. Immunol Rev, 212, 185-202 (2006) (Pubitemid 44116709)
92. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin & et al.: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature, 359, 693-9 (1992)
93. Czarniecki, C. W., H. H. Chiu, G. H. Wong, S. M. McCabe & M. A. Palladino: Transforming growth factorbeta 1 modulates the expression of class II histocompatibility antigens on human cells. J Immunol, 140, 4217-23 (1988)
94. Zhang, X., L. Giangreco, H. E. Broome, C. M. Dargan & S. L. Swain: Control of CD4 effector fate: transforminggrowth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J Exp Med, 182, 699-709 (1995)
95. King, C., J. Davies, R. Mueller, M. S. Lee, T. Krahl, B. Yeung, E. O'Connor & N. Sarvetnick: TGF-beta1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity, 8, 601-13 (1998) (Pubitemid 28264751)
96. Peng, Y., Y. Laouar, M. O. Li, E. A. Green & R. A. Flavell: TGF-beta regulates in vivo expansion of Foxp3- expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc Natl Acad Sci U S A, 101, 4572-7 (2004) (Pubitemid 38437452)
97. Andre, I., A. Gonzalez, B. Wang, J. Katz, C. Benoist & D. Mathis: Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci U S A, 93, 2260-3 (1996) (Pubitemid 26104338)
98. Jarpe, A. J., M. R. Hickman, J. T. Anderson, W. E. Winter & A. B. Peck: Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes. Reg Immunol, 3, 305-17 (1990)
99. Miller, B. J., M. C. Appel, J. J. O'Neil & L. S. Wicker: Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol, 140, 52-8 (1988) (Pubitemid 18050680)
100. Bendelac, A., C. Carnaud, C. Boitard & J. F. Bach: Syngeneic transfer of autoimmune diabetes from diabeticNOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. J Exp Med, 166, 823-32 (1987) (Pubitemid 18024228)
101. Bradley, B. J., K. Haskins, F. G. La Rosa & K. J. Lafferty: CD8 T cells are not required for islet destruction induced by a CD4+ islet-specific T-cell clone. Diabetes, 41, 1603-8 (1992)
102. Wicker, L. S., E. H. Leiter, J. A. Todd, R. J. Renjilian, E. Peterson, P. A. Fischer, P. L. Podolin, M. Zijlstra, R. Jaenisch & L. B. Peterson: Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes, 43, 500-4 (1994) (Pubitemid 24064260)
103. Sumida, T., M. Furukawa, A. Sakamoto, T. Namekawa, T. Maeda, M. Zijlstra, I. Iwamoto, T. Koike, S. Yoshida, H. Tomioka & et al.: Prevention of insulitis and diabetes in beta 2-microglobulin-deficient non-obese diabetic mice. Int Immunol, 6, 1445-9 (1994) (Pubitemid 24296861)
104. Serreze, D. V., E. H. Leiter, G. J. Christianson, D. Greiner & D. C. Roopenian: Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes, 43, 505-9 (1994)
105. Katz, J., C. Benoist & D. Mathis: Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur J Immunol, 23, 3358-60 (1993) (Pubitemid 23353790)
106. Efrat, S., D. Serreze, A. Svetlanov, C. M. Post, E. A. Johnson, K. Herold & M. Horwitz: Adenovirus early region 3 (E3) immunomodulatory genes decrease the incidence of autoimmune diabetes in NOD mice. Diabetes, 50, 980-4 (2001) (Pubitemid 32374527)
107. Kagi, D., B. Odermatt, P. Seiler, R. M. Zinkernagel, T. W. Mak & H. Hengartner: Reduced incidence anddelayed onset of diabetes in perforin-deficient nonobese diabetic mice. J Exp Med, 186, 989-97 (1997) (Pubitemid 27441144)
108. Wong, F. S., I. Visintin, L. Wen, J. Granata, R. Flavell & C. A. Janeway: The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice. J Exp Med, 187, 1985-93 (1998) (Pubitemid 28285568)
109. Wong, F. S., W. Du, I. J. Thomas & L. Wen: The influence of the major histocompatibility complex ondevelopment of autoimmune diabetes in RIP-B7.1 mice. Diabetes, 54, 2032-40 (2005) (Pubitemid 40911266)
110. Stephens, L. A. & T. W. Kay: Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse. Int Immunol, 7, 1885-95 (1995) (Pubitemid 26003695)
111. Sharpe, A. H., E. J. Wherry, R. Ahmed & G. J. Freeman: The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol, 8, 239-45 (2007) (Pubitemid 46745373)
112. Greenwald, R. J., G. J. Freeman & A. H. Sharpe: The B7 family revisited. Annu Rev Immunol, 23, 515-48 (2005) (Pubitemid 40563179)
113. Khoury, S. J. & M. H. Sayegh: The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity, 20, 529-38 (2004) (Pubitemid 38638123)
114. Dong, C., R. I. Nurieva & D. V. Prasad: Immune regulation by novel costimulatory molecules. Immunol Res, 28, 39-48 (2003) (Pubitemid 37088541)
115. Fife, B. T., I. Guleria, M. Gubbels Bupp, T. N. Eagar, Q. Tang, H. Bour-Jordan, H. Yagita, M. Azuma, M. H.Sayegh & J. A. Bluestone: Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J Exp Med, 203, 2737-47 (2006) (Pubitemid 44833349)
116. Keir, M. E., S. C. Liang, I. Guleria, Y. E. Latchman, A. Qipo, L. A. Albacker, M. Koulmanda, G. J. Freeman, M. H. Sayegh & A. H. Sharpe: Tissue expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med, 203, 883-95 (2006)
117. Sperling, A. I. & J. A. Bluestone: The complexities of T-cell co-stimulation: CD28 and beyond. Immunol Rev, 153, 155-82 (1996) (Pubitemid 27010767)
118. Krummel, M. F. & J. P. Allison: CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med, 183, 2533-40 (1996) (Pubitemid 26192363)
119. Krummel, M. F. & J. P. Allison: CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med, 182, 459-65 (1995)
120. Eagar, T. N., N. J. Karandikar, J. A. Bluestone & S. D. Miller: The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. Eur J Immunol, 32, 972-81 (2002) (Pubitemid 34428812)
121. Perez, V. L., L. Van Parijs, A. Biuckians, X. X. Zheng, T. B. Strom & A. K. Abbas: Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity, 6, 411-7 (1997) (Pubitemid 27208196)
122. Luhder, F., P. Hoglund, J. P. Allison, C. Benoist & D. Mathis: Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J Exp Med, 187, 427-32 (1998) (Pubitemid 28080071)
123. Lin, H., J. C. Rathmell, G. S. Gray, C. B. Thompson, J. M. Leiden & M. L. Alegre: Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. J Exp Med, 188, 199-204 (1998) (Pubitemid 28328618)
124. McCoy, K., M. Camberis & G. L. Gros: Protective immunity to nematode infection is induced by CTLA-4 blockade. J Exp Med, 186, 183-7 (1997) (Pubitemid 27328018)
125. Leach, D. R., M. F. Krummel & J. P. Allison: Enhancement of antitumor immunity by CTLA-4 blockade. Science, 271, 1734-6 (1996) (Pubitemid 26102823)
126. Karandikar, N. J., C. L. Vanderlugt, T. L. Walunas, S. D. Miller & J. A. Bluestone: CTLA-4: a negative regulator of autoimmune disease. J Exp Med, 184, 783-8 (1996) (Pubitemid 26324135)
127. Griffin, M. D., D. K. Hong, P. O. Holman, K. M. Lee, M. J. Whitters, S. M. O'Herrin, F. Fallarino, M. Collins, D. M. Segal, T. F. Gajewski, D. M. Kranz & J. A. Bluestone: Blockade of T cell activation using a surface-linked singlechain antibody to CTLA-4 (CD152). J Immunol, 164, 4433-42 (2000) (Pubitemid 30238037)
128. Fife, B. T., M. D. Griffin, A. K. Abbas, R. M. Locksley & J. A. Bluestone: Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist. J Clin Invest, 116, 2252-61 (2006) (Pubitemid 44162335)
129. Mackay, F. & S. L. Kalled: TNF ligands and receptors in autoimmunity: an update. Curr Opin Immunol, 14, 783-90 (2002) (Pubitemid 35292427)
130. Silva, D. G., L. Socha, B. Charlton, W. Cowden & N. Petrovsky: Autoimmune diabetes in the NOD mouse: an essential role of Fas-FasL signaling in beta cell apoptosis. Ann N Y Acad Sci, 1005, 161-5 (2003) (Pubitemid 38507745)
131. Suarez-Pinzon, W., O. Sorensen, R. C. Bleackley, J. F. Elliott, R. V. Rajotte & A. Rabinovitch: Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets. Diabetes, 48, 21-8 (1999) (Pubitemid 29019348)
132. Stassi, G., R. De Maria, G. Trucco, W. Rudert, R. Testi, A. Galluzzo, C. Giordano & M. Trucco: Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med, 186, 1193-200 (1997) (Pubitemid 27469014)
133. Sung, H. H., J. H. Juang, Y. C. Lin, C. H. Kuo, J. T. Hung, A. Chen, D. M. Chang, S. Y. Chang, S. L. Hsieh & H. K. Sytwu: Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice. J Exp Med, 199, 1143-51 (2004) (Pubitemid 38619910)
134. Pitti, R. M., S. A. Marsters, D. A. Lawrence, M. Roy, F. C. Kischkel, P. Dowd, A. Huang, C. J. Donahue, S. W. Sherwood, D. T. Baldwin, P. J. Godowski, W. I. Wood, A. L. Gurney, K. J. Hillan, R. L. Cohen, A. D. Goddard, D. Botstein & A. Ashkenazi: Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature, 396, 699-703 (1998) (Pubitemid 29003951)
135. Yu, K. Y., B. Kwon, J. Ni, Y. Zhai, R. Ebner & B. S. Kwon: A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem, 274, 13733-6 (1999)
136. Migone, T. S., J. Zhang, X. Luo, L. Zhuang, C. Chen, B. Hu, J. S. Hong, J. W. Perry, S. F. Chen, J. X. Zhou, Y. H. Cho, S. Ullrich, P. Kanakaraj, J. Carrell, E. Boyd, H. S. Olsen, G. Hu, L. Pukac, D. Liu, J. Ni, S. Kim, R. Gentz, P. Feng, P. A. Moore, S. M. Ruben & P. Wei: TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity, 16, 479-92 (2002) (Pubitemid 34260924)
137. Savinov, A. Y., A. Tcherepanov, E. A. Green, R. A. Flavell & A. V. Chervonsky: Contribution of Fas to diabetes development. Proc Natl Acad Sci U S A, 100, 628-32 (2003) (Pubitemid 36126103)
138. Wang, J., J. C. Lo, A. Foster, P. Yu, H. M. Chen, Y. Wang, K. Tamada, L. Chen & Y. X. Fu: The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J Clin Invest, 108, 1771-80 (2001) (Pubitemid 34015122)
139. DeBenedette, M. A., A. Shahinian, T. W. Mak & T. H. Watts: Costimulation of CD28- T lymphocytes by 4-1BB ligand. J Immunol, 158, 551-9 (1997) (Pubitemid 127492629)
140. Mittler, R. S., T. S. Bailey, K. Klussman, M. D. Trailsmith & M. K. Hoffmann: Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy. J Exp Med, 190, 1535-40 (1999)
141. Sun, Y., X. Lin, H. M. Chen, Q. Wu, S. K. Subudhi, L. Chen & Y. X. Fu: Administration of agonistic anti-4- 1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis. J Immunol, 168, 1457-65 (2002) (Pubitemid 34094519)
142. Sytwu, H. K., W. D. Lin, S. R. Roffler, J. T. Hung, H. S. Sung, C. H. Wang, T. L. Cheng, S. C. Tsou, S. C. Hsi & K. L. Shen: Anti-4-1BB-based immunotherapy for autoimmune diabetes: lessons from a transgenic non-obese diabetic (NOD) model. J Autoimmun, 21, 247-54 (2003) (Pubitemid 37410112)
143. Shapiro, A. M., C. Ricordi, B. J. Hering, H. Auchincloss, R. Lindblad, R. P. Robertson, A. Secchi, M. D. Brendel, T. Berney, D. C. Brennan, E. Cagliero, R. Alejandro, E. A. Ryan, B. DiMercurio, P. Morel, K. S. Polonsky, J. A. Reems, R. G. Bretzel, F. Bertuzzi, T. Froud, R. Kandaswamy, D. E. Sutherland, G. Eisenbarth, M. Segal, J. Preiksaitis, G. S. Korbutt, F. B. Barton, L. Viviano, V. Seyfert-Margolis, J. Bluestone & J. R. Lakey: International trial of the Edmonton protocol for islettransplantation. N Engl J Med, 355, 1318-30 (2006) (Pubitemid 44465460)
144. Ryan, E. A., B. W. Paty, P. A. Senior, D. Bigam, E. Alfadhli, N. M. Kneteman, J. R. Lakey & A. M. Shapiro: Five-year follow-up after clinical islet transplantation. Diabetes, 54, 2060-9 (2005) (Pubitemid 40911269)
145. Biarnes, M., M. Montolio, V. Nacher, M. Raurell, J. Soler & E. Montanya: Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes, 51, 66-72 (2002) (Pubitemid 34517981)
146. Davalli, A. M., Y. Ogawa, C. Ricordi, D. W. Scharp, S. Bonner-Weir & G. C. Weir: A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. Transplantation, 59, 817-20 (1995)
147. Ozmen, L., K. N. Ekdahl, G. Elgue, R. Larsson, O. Korsgren & B. Nilsson: Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes, 51, 1779-84 (2002) (Pubitemid 34564290)
148. Moberg, L., H. Johansson, A. Lukinius, C. Berne, A. Foss, R. Kallen, O. Ostraat, K. Salmela, A. Tibell, G. Tufveson, G. Elgue, K. Nilsson Ekdahl, O. Korsgren & B. Nilsson: Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet, 360, 2039-45 (2002) (Pubitemid 36026584)
149. Weber, M., S. Deng, T. Kucher, A. Shaked, R. J. Ketchum & K. L. Brayman: Adenoviral transfection of isolated pancreatic islets: a study of programmed cell death (apoptosis) and islet function. J Surg Res, 69, 23-32 (1997) (Pubitemid 27265822)
150. Loiler, S. A., T. J. Conlon, S. Song, Q. Tang, K. H. Warrington, A. Agarwal, M. Kapturczak, C. Li, C. Ricordi, M. A. Atkinson, N. Muzyczka & T. R. Flotte: Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver. Gene Ther, 10, 1551-8 (2003) (Pubitemid 37063260)
151. Zufferey, R., D. Nagy, R. J. Mandel, L. Naldini & D. Trono: Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol, 15, 871-5 (1997)
152. Naldini, L., U. Blomer, F. H. Gage, D. Trono & I. M. Verma: Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A, 93, 11382-8 (1996) (Pubitemid 26347130)
153. Bottino, R., P. Lemarchand, M. Trucco & N. Giannoukakis: Gene- and cell-based therapeutics for type I diabetes mellitus. Gene Ther, 10, 875-89 (2003) (Pubitemid 36665298)
154. Gallichan, W. S., T. Kafri, T. Krahl, I. M. Verma & N. Sarvetnick: Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum Gene Ther, 9, 2717-26 (1998) (Pubitemid 29027015)
155. Allison, J., I. L. Campbell, G. Morahan, T. E. Mandel, L. C. Harrison & J. F. Miller: Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature, 333, 529-33 (1988)
156. Lo, D., L. C. Burkly, G. Widera, C. Cowing, R. A. Flavell, R. D. Palmiter & R. L. Brinster: Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell, 53, 159-68 (1988)